Table 3 Summary statistics for clinical and QoL outcomes
Mini implants | Conventional implants | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Outcome | Baseline (n = 22) | Operation (n = 22) | 24 h (n = 22) | 1 week (n = 22) | 2 months (n = 20) | 6 months (n = 19) | Baseline (n = 23) | Operation (n = 23) | 24 h (n = 23) | 1 week (n = 23) | 2 months (n = 23) | 6 months (n = 22) |
Glucose Mean (sd) Median (IQR) | 145.18 (54.00) | 193.95 (86.84) | 198.84 (111.76) | 185.35 (81.02) | 189.21 (87.11) | 187.86 (74.21) | ||||||
132 (109 to 184) | 172 (152 to 204) | 170 (99 to 241) | 164 (126 to 230) | 161 (138 to 208) | 180.5 (135 to 246) | |||||||
Paina Mean (sd) Median (IQR) | 6.5 (5.5) | 3.05 (2.6) | 16.8 (19.38) | 11.58 (14.6) | 4.3 (3.2) | 38 (32.2) | ||||||
4 (3 to 10) | 3 (0 to 5) | 6.5 (2 to 27) | 5 (3 to 15) | 3 (1 to 7) | 37 (7 to 69) | |||||||
Analgesic consumption | 15/22 (68.18%) | 8/22 (36.36%) | 20/23 (86.96%) | 16/23 (69.57%) | ||||||||
OHIP-20bMean (sd) Median (IQR) | 76.5 (20.1) | 66.5 (28.3) | 40.9 (18.1) | 83.3 (23.1) | 79.6 (24.9) | 56.2 (29.6) | ||||||
78.5 (60 to 92) | 65 (43 to 80) | 36 (25 to 58) | 81 (64 to 100) | 82 (58 to 105) | 43 (29 to 81) | |||||||
Affects general healthc | 14/22 (63.6%) | 5/20 (25%) | 5/19 (26.3%) | 12/23 (52.2%) | 7/23 (30.4%) | 4/22 (18.2%) | ||||||
Implant Failure | 1 | 0 | 0 | 0 | ||||||||